Why this seasoned money manager sees real upside for this innovative B2B tech startup. on 10/26/2021. Learn More

ProMIS Neurosciences Inc.

PMN:TSX; ARFXF:OTCQB

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

ProMIS Neurosciences is a development stage biotechnology company whose unique core technology is the ability to rationally predict the site and shape (conformation) of novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of proteins. In neurodegenerative diseases, such as Alzheimerís, ALS and Parkinsonís disease, the DSEís are misfolded regions on otherwise normal proteins. In the infectious disease setting, these disease-specific epitopes represent peptide antigens that can be used as an essential component to create accurate and sensitive serological assays to detect the presence of antibodies that arise in response to a specific infection, such as COVID-19.